Author

A. Mallipatna

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Bisht· 1 shared A. Ghosh· 1 shared D. SA· 1 shared G. Dudeja· 1 shared N. Guha· 1 shared R. Kannan· 1 shared R. Shetty· 1 shared S. Heymans· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Bisht

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Enhanced epithelial to mesenchymal transition and chemoresistance in advanced Retinoblastoma tumors is driven by miR-181a

V. Suresh Babu, A. Bisht, A. Mallipatna, D. SA, G. Dudeja, R. Kannan, R. Shetty, S. Heymans, N. Guha, A. Ghosh

This study identifies miR-181a-5p as a regulator of EMT and chemoresistance in advanced retinoblastoma by reversing drug resistance through targeting ZEB1 and SNAI2.

bioRxiv · Jul 25, 2022 · PreprintCancer Biology